Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 123635
Published online Aug 15, 2026. doi: 10.4239/wjd.123635
Published online Aug 15, 2026. doi: 10.4239/wjd.123635
Table 2 Comparison of baseline characteristics between the control and observation group
| Indicators | Control group | Observation group | Z/χ2 | P value |
| Number of cases | 222 | 222 | ||
| Age (years) | 26.00 (25.00-31.00) | 32.00 (28.00-36.25) | 9.381 | 0.000 |
| Height (m) | 1.62 (1.56-1.68) | 1.61 (1.57-1.67) | -0.276 | 0.782 |
| Pre-pregnancy weight (kg) | 57.00 (49.00-64.00) | 70.00 (61.00-81.00) | 11.395 | 0.000 |
| Pre-pregnancy BMI (kg/m2) | 21.32 (18.64-24.40) | 26.71 (23.30-30.84) | 11.114 | 0.000 |
| Mid-pregnancy weight (kg) | 57.00 (48.00-66.00) | 72.00 (65.00-82.00) | 12.773 | 0.000 |
| Mid-pregnancy BMI (kg/m2) | 21.26 (18.64-24.97) | 27.96 (24.28-30.83) | 12.215 | 0.000 |
| Birth history | ||||
| Yes | 116 (52.25) | 109 (49.10) | 0.442 | 0.506 |
| No | 106 (47.75) | 113 (50.90) |
- Citation: Xu XP, Ding S, Che YM, Li J, Zhang Z, Qian C. Expression and clinical value of the plasma peroxiredoxin family in early pregnancy for predicting subsequent gestational diabetes mellitus. World J Diabetes 2026; 17(8): 123635
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/123635.htm
- DOI: https://dx.doi.org/10.4239/wjd.123635